Intuitive Surgical, Inc. (ISRG) — Fair Value Analysis

Base-case fair value (P50): $381.19 · Current price: $426.01 · Verdict: Fairly Valued

The Verdict on ISRG

Intuitive Surgical Inc (ISRG) is currently deemed Fairly Valued based on our latest Monte Carlo simulations. At a market price of $426.01, our comprehensive analysis yields a median fair value (P50) for ISRG at $381.19. This suggests a narrow -10.5% variance, indicating that the market's current valuation closely aligns with the intrinsic value derived from thousands of forward-looking financial scenarios. Our assessment points to a situation where ISRG's stock price, despite potential short-term movements, fundamentally tracks its estimated fair value. This verdict is a direct result of evaluating the company's financial health and future prospects through rigorous probabilistic modeling.

How ISRG stacks up against peers

Intuitive Surgical Inc (ISRG) holds an average quality tier, reflecting its operational and financial health compared to its broader sector. This rating indicates that while ISRG maintains a solid foundational performance, it neither significantly exceeds nor lags its industry counterparts in core financial metrics and efficiency. Our Monte Carlo simulations meticulously incorporate this average quality, ensuring the median fair value of $381.19 accurately reflects a company with these characteristics. The current trading price of $426.01 aligns well with this assessment, further supporting the Fairly Valued verdict and the -10.5% outlook. This consistent pricing reflects a market recognizing ISRG's stable but not exceptional standing.

What this means for investors

For investors assessing Intuitive Surgical Inc (ISRG), the Fairly Valued verdict implies that the stock's current price of $426.01 largely reflects its intrinsic value, with our median fair value standing at $381.19. The narrow -10.5% difference further supports this alignment, suggesting limited immediate mispricing. Given ISRG's average quality tier in terms of operational and financial health, the market appears to be efficiently pricing the company's current performance and future prospects based on our Monte Carlo simulations. This scenario suggests that significant short-term arbitrage opportunities are not evident at this juncture. Investors looking for deeper insights into potential upside or downside scenarios, beyond the P50, can leverage FairCurve's comprehensive models. Sign up for FairCurve to see the full bear/bull distribution and track ISRG's fair value as new fundamentals are released.